Icu Medical (ICUI) Net Income towards Common Stockholders (2009 - 2026)

Icu Medical's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $30.7 million for Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 339.18% year-over-year to $30.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.4 million (up 159.85% YoY) and the FY2025 annual result came in at $1.9 million, up 101.63% from the prior year.
• Net Income towards Common Stockholders was $30.7 million for Q1 2026 at Icu Medical, up from -$13.2 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $34.8 million in Q2 2025 and bottomed at -$38.1 million in Q1 2022.
• A 5-year average of -$10.0 million and a median of -$13.2 million in 2022 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders sank 555.69% — and 2026, when it jumped 339.18%.
• Icu Medical's Net Income towards Common Stockholders stood at -$15.5 million in 2022, then slipped by 10.37% to -$17.1 million in 2023, then slumped by 38.96% to -$23.8 million in 2024, then soared by 44.4% to -$13.2 million in 2025, then soared by 332.01% to $30.7 million in 2026.
• Business Quant data shows ICUI's Net Income towards Common Stockholders at $30.7 million in Q1 2026, -$13.2 million in Q4 2025, and -$1.9 million in Q3 2025.